Pharmaceuticals Insights- Page 2 of 5

The current state of aseptic processing & fill-finish manufacturing

Providing patients with contaminant-free drug products that are as effective and safe as possible is the core demand of the fill-finish process.

How to maintain low temperatures in your plasma fractionation process

Keeping your plasma fractionation process and facility cold requires careful planning and design.

DNA strand used in oligonucleotide manufacturing

Best practices in oligonucleotide manufacturing

After decades of research, the oligonucleotide industry has reached a tipping point and is experiencing a huge surge of interest and momentum.

Plasma facility delivery: 3 reasons to choose IPD

When it comes to highly complex plasma fractionation facilities, integrated project delivery is an optimal way to design and build.

5 current trends that will shape the life sciences in 2021 and beyond

Many of the life sciences trends that are driving innovation today were here pre-COVID, but the pandemic was an accelerant. For all that it took, it gave life science researchers and developers new momentum, and from that momentum, hope.

Considerations for scaling your oligo manufacturing facility

5 questions to ask when designing oligonucleotide facilities

As industry momentum continues, oligonucleotide manufacturers are making the leap from benchtop production to commercial scale. The challenges of large-scale oligo manufacturing, however, are exponential in comparison to small scale, lab-based operations.

Precision medicine diagnostics are driving the need for flexible facility design

Precision medicine is based on the idea that each of us is different and may not react the same way to a particular treatment.

4 strategies to help your facility respond to the changing animal health market

The animal health market is changing. These four strategies will help your facility change with it.

Behind every rapid response is a strong regulatory strategy

During a global pandemic, the pharmaceutical industry must juggle the need for speed and the need to protect patient safety. A strong regulatory strategy makes it possible to accelerate drug development without getting slowed down by compliance considerations.

Oral solid dosage manufacturing

Oral solid dosage (OSD) products can take several different shapes, and with those different forms comes different production techniques and facility designs. Here’s what is involved with manufacturing an orally-ingested drug product.